RESOLUTIONPHARMA
Liquidation judiciaire since 21 Jan 2025
Business purpose.
Commerce de gros (commerce interentreprises) de produits pharmaceutiques non remboursés. Achat et vente de produits pharmaceutiques et cosmétiques non remboursés.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 9 Dec 2020
- Share capital
- 100.00 EUR
- Registered with the trade register
- 15 Dec 2020
- Financial year end
- 31/12
- Establishments
- 1
Directors
- CLAUDE DARMON 64 years old, 09/1962 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- MIFAZA via CLAUDE DARMON
- CDMC CONSULTANTS via CLAUDE DARMON
Court decisions
Decisions published by the French Court of Cassation (Judilibre) that cite this company by its SIREN number. Individuals are pseudonymised.
- Judgment, Tribunal des activités économiques de Paris 21 Jan 2025 · no. 2024082122
Other companies at the same address
More than 500 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
20 / 100 E
Confidence: high
Ongoing insolvency proceedings cap this score, whatever the other components say.
- No insolvency proceedings
- 0.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (5.9 years)
- 11.9 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Legal notices
-
Insolvency proceedings 6 Feb 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Paris
- Nature :
- Jugement d'ouverture de liquidation judiciaire
- Date of judgment :
- 21/01/2025
- Detail :
- Jugement prononçant la liquidation judiciaire simplifiée, date de cessation des paiements le 23 décembre 2024,désignant liquidateur Selarl Guigon associes en la personne de Me Pierre-Adrien Guigon 9 rue du Mont Thabor 75001 Paris. Les déclarations des créances sont à adresser au mandataire judiciaire ou sur le portail électronique prévu par les articles L. 814-2 et L. 814-13 du code de commerce dans les deux mois à compter de la publication au Bodacc.
BODACC A n 20250026, annonce n 2588 · Proof of publication (PDF)
-
Amendment 4 Aug 2023
- Court :
- Greffe du Tribunal de Commerce de Paris
- Amendment :
- modification survenue sur l'administration
BODACC B n 20230149, annonce n 1177 · Proof of publication (PDF)
-
Incorporation 24 Dec 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
BODACC A n 20200250, annonce n 1292 · Proof of publication (PDF)
Change history
- employee_range 01 → NN 4 Nov 2026
- employee_range 01 → NN 3 Nov 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- registered_address (empty) → 34 avenue des Champs-Élysées 75008 Paris 3 Oct 2026
- capital (empty) → 100.00 3 Oct 2026
- proceedings (empty) → Liquidation judiciaire 2 Oct 2026
Frequently asked questions about RESOLUTIONPHARMA
- What is the SIREN number of RESOLUTIONPHARMA?
- The SIREN number of RESOLUTIONPHARMA is 892088857. Its intra-community VAT number is FR14892088857.
- Where is the head office of RESOLUTIONPHARMA?
- Head office address: 34 AVENUE DES CHAMPS ELYSEES, 75008 PARIS.
- When was RESOLUTIONPHARMA founded?
- RESOLUTIONPHARMA was founded on 9 Dec 2020.
- What does RESOLUTIONPHARMA do?
- Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
- Who runs RESOLUTIONPHARMA?
- The officer listed in the register is CLAUDE DARMON (President de SAS).
- Is RESOLUTIONPHARMA subject to insolvency proceedings?
- Yes: Liquidation judiciaire. Opening judgment dated 21 Jan 2025.